Biomat USA F-4 Registration of securities (foreign)

Exhibit 3.9.2

Interactive Commercial Information from the Registries of Commerce of Spain

REGISTRY OF COMMERCE OF BARCELONA

Issued on: 05/19/2011 at 11:26 a.m.

BYLAWS

GENERAL DATA

Name:	MOVACO SA
Start of Operations:	09/21/1987
Corporate Address:	CAN GUASCH S/N POLÍGONO LEVANTE PARETS
Duration:	INDEFINITE
C.I.F. [Tax Identification Code]:	A58426008
Registry Information:	Sheet B-112975
	Volume 41752
	Page 199

Corporate Purpose: THE MANUFACTURE, IMPORT, EXPORT, PREPARATION, DISTRIBUTION AND SALE OF REAGENTS, CHEMICALS, IN PARTICULAR THOSE DESTINED FOR LABORATORIES AND HEALTH CENTERS, AND MATERIALS, DEVICES AND INSTRUMENTS FOR MEDICAL AND SURGICAL USE OR THE MANUFACTURE, IMPORT, EXPORT, PREPARATION, DISTRIBUTION, SALE, TECHNICAL SUPPORT AND AFTER SALES SERVICE OF REAGENTS, THERAPEUTIC, DIETARY AND PARAPHARMACEUTICAL PRODUCTS, ETC. THE MANUFACTURE, IMPORT, EXPORT, PREPARATION, DISTRIBUTION, SALE, TECHNICAL SUPPORT AND AFTER SALES SERVICE OF REAGENTS, THERAPEUTIC, DIETARY AND PARAPHARMACEUTICAL PRODUCTS, PHARMACEUTICAL SPECIALTIES.

Structure of the governing body:Joint/Indistinct Managers

Last accounts deposited:2009

VALID TITLE REGISTRATION REQUESTS

There are no valid title registration requests

SPECIAL SITUATIONS

There are no special situations

BYLAWS

BYLAWS: TITLE I. NAME, PURPOSE, ADDRESS AND DURATION. Article 1.- The Company called MOVACO, S.A., is a commercial company, established as a corporation, under Spanish law and is it governed by these Bylaws and, in all matters not covered herein or in all mandatory matters, by the Consolidated Text of the Corporations Act of December 22, 1989, the Commercial Code and other applicable current provisions. Article 2.- The company’s purpose is the manufacture, import, export, preparation, distribution, sale, technical support and after sales service of reagents, therapeutic, dietary and parapharmaceutical products, pharmaceutical and consumer health care specialties, medicines and chemical products. Sales, marketing and distribution of any medical-surgical material, device, instrument and product that has an application or direct or indirect use related to health in the broadest sense, including the sale of medical books and the marketing of clinical and office furniture in general. Maintenance, repair and leasing of medical, surgical, therapeutic and optical equipment and supplies, of an electrical and electronic type; maintenance and repair of equipment and facilities for lifting and horizontal transportation equipment, and in particular elevators, freight elevators, escalators, conveyor belts and chains, mechanical and pneumatic elevators, pneumatic tubes and distribution mechanisms. Manufacture, sales, marketing, export and distribution of all type of material, computer products and hardware and software activities taking part both in certain phases of their execution and/or programming and in the whole process, development, implementation and integration of technology and/or information systems, and typing and data recording or capture services via electronic means and the digitalization or conversion of document formats through the use of information and telecommunications technologies; tasks covering the planning, analysis, design, construction, testing and maintenance of information systems and computer programs and applications; preventive, corrective and perfective maintenance and the repair of equipment and hardware and software systems for information processing, as well as the broadcasting and receiving equipment thereof and the corresponding systems and transmission methods. Voice and/or data communication services, the lease of circuits for voice and/or data transmission and in general value added services on telecommunications networks: commissioning, monitoring, management and control of computer equipment and systems and telematic infrastructures for the operation of computer programs and applications, and in general technology evaluation and certification services. All those activities for which the Law requires special requirements which are not met by this Company are excluded from the corporate purpose. Article 3.- The Company establishes its corporate offices in Polígono Levante, Calle Can Guasch s/n, 08150 Parets del Vallés, and may decide to relocate within the same town, establish branches, offices or agencies anywhere in Spain or abroad, by agreement of the Governing Body. Article 4.- The duration of the Company will be indefinite; it began operations on September 21, 1987. Article 5.- The fiscal year begins on the first day of January and ends on December 31st of each year, with the exception of the year ending on December 31, 1997, which began on August 1, 1997. TITLE II. SHARE CAPITAL AND SHARES. Article 6.- The share capital is set at 2,404,601 Euros, represented by 80,020 registered shares, each with a nominal value of 30.05 Euros, numbered consecutively from 1 to 80,020, both included. The shares will be represented by a certificate, share books will be issued; they may incorporate one or more shares of the same series and will contain all the legal provisions of

Article 53 of the Corporations Act. The shares are subscribed and paid in full. The Company shall keep a Shares Registry Book in which the successive transfers of shares will be recorded, as well as the establishment of any real rights and other liens. Article 7.- The Company considers the shares to be indivisible, so it will only recognize one owner per share. The co-owners of any share must be represented before the Company by a single person, notwithstanding the fact they will be severally and jointly liable for all liabilities arising from ownership of the share. TITLE III. RIGHTS AND OBLIGATIONS OF THE SHAREHOLDERS. Article 8.- The acquisition of one or more shares implies agreement with and acceptance of these Bylaws, and being a shareholder implies, without exception, not only the acceptance of these Bylaws, but also compliance with the agreements of the General Shareholders Assembly, with the decisions of the Governing Body, and compliance with all other obligations arising from the deed of incorporation or the application or interpretation of these Bylaws, notwithstanding, however, the rights and remedies the Law grants to shareholders. Article 9.- Each share grants its legitimate holder the status or condition of being a shareholder with the rights and obligations inherent thereto, in accordance with these Bylaws and the legal dispositions in force, and among them: 1.- Proportionate share in the Company’s profits. 2.- Proportionate share in the Company’s assets resulting from the Company’s liquidation. 3.- The right of first refusal in the event of new share issues. 4.- The right to attend and vote in the General Assemblies. 5.- The right to transfer, pledge, offer as collateral or otherwise dispose of the legal or beneficial ownership of their shares, as provided in these Bylaws. 6.- All others conferred by the Law. Article 10.- The shares may be transferred by any means permitted by Law. Nevertheless, the shareholders and alternatively the Company will have the right of first refusal to acquire all or part of the shares that any shareholder wishes to dispose of inter vivos for consideration to any person other than their spouse, progenitors or progeny to which end they must notify the Company’s Managers as to the numbers of the shares to be transferred, the name and details of the alleged purchaser and the price offered. The Managers shall notify this immediately to the other shareholders, who shall have a period of 30 days to exercise their rights of first refusal. If there were more than one applicant, the shares will be distributed among them in proportion to the number of shares they already hold. In the event there is a surplus which cannot be apportioned, it will be awarded by raffling the remaining shares one by one among the applicants, excluding from the successive draws those shareholders which have been awarded a share in the previous draws. If none of the shareholders stated their intent to acquire the offered shares, or there is a surplus, the Company may acquire them in the legally established manner, within another thirty days. After notifying the selling shareholder that neither the shareholders nor the Company are interested in purchasing the offered shares, or after the aforementioned periods have expired without any notification, the former may freely transfer the shares in question to the mentioned person at the mentioned price, provided they do so within two months following the day on which their right was confirmed. After this period has elapsed without the transfer taking place, the aforementioned formalities must be repeated to try the sale again. In cases of judicial transmission, the same formalities and deadlines will be followed so that the shareholders and alternatively the Company can have the right of first refusal for the shares, with said deadlines starting to count as of the time the person who acquired the shares notifies the Company’s Managers of the award formalized in their favor. The same right of first refusal will exist in case of a donation or “causa mortis” transfer in favor of persons other than the spouse or the shareholder’s direct ascendants or descendants, in which case the heirs, legatees or grantees must notify the Company’s Managers of the acquisition, at which point the procedures and deadlines foreseen in the preceding paragraphs shall apply. The price at which the shareholders, who exercise their right of first refusal, or the Company in its case, may acquire the

offered shares, shall be the real value thereof, unless, in transfers for consideration, the price offered by the alleged acquirer is less. In the event of a lack of agreement about the actual value, it shall be determined by two experts, one appointed by each party, and in the event of a disagreement between them, by a third expert appointed by mutual agreement of both parties, and failing agreement by a Judge. The Company will not recognize anyone as a shareholder if they acquired the shares without complying with the above requirements, nor until they notify the Company of the already made acquisition. If a shareholder who wishes to exercise the right of first refusal cannot exercise it as a result of a legal provision that impedes it, they may appoint a natural or legal person who may take their place and rights for the aforementioned purposes. Notwithstanding the foregoing, if the acquisition by a foreign national requires administrative authorization, they must state whether or not they intend to acquire the shares within the scheduled deadline, and if they do intend to acquire them, the deadlines specified in this article will be suspended, until the final decision on the matter has been made by the competent authority, it being understood as denied if after twelve months nothing has been heard. The party stating their intent to acquire the shares must start the procedure within a maximum of one month counted from the date of the affirmative answer. In order to divulge the provisions in this article, the certificates for the shares shall carry the words: “The transmission of this share is subject to the limitations established in Article 10.- of the Corporate Bylaws.” TITLE IV. GOVERNANCE AND MANAGEMENT OF THE COMPANY. Article 11.- The governance and management of the Company shall be conferred upon: a) The General Shareholders Assembly. b) Three Joint and Several Managers. This notwithstanding any other positions that may be appointed pursuant to the bylaws or legal imperatives. FIRST CHAPTER: ON THE GENERAL ASSEMBLY. Article 12.- The legally established General Shareholders Assembly represents all the shareholders and its decisions, adopted pursuant to these Bylaws, will be binding on all shareholders, including the dissenting ones and those who did not take part in the vote, notwithstanding, however, the rights conferred by the Law to shareholders. Article 13.- The General Shareholders Assemblies may be Ordinary or Extraordinary. The Ordinary General Shareholders Assembly will be held within the first six months of each fiscal year to review the company’s management, approve, in its case, the previous year’s accounts and decide on the distribution of results. All other Assemblies shall be considered Extraordinary. The Extraordinary Assemblies will convene whenever the Company’s Governing Body deems appropriate or at the request of shareholders representing at least 5% of the share capital, stating in the request the matters to be discussed at the Assembly. In this case, the Assembly must be convened to be held within thirty days from the date on which the Governing Body received a notarized request to convene the Assembly. Article 14.- The convening of the Assembly, whether Ordinary or Extraordinary, shall be through an announcement published in the Official Gazette of the Registry of Commerce, as well as in one of the largest circulation newspapers in the province of the corporate address. The announcement will be published at least fifteen days before the date set for the Assembly, except in the event of mergers and splits, in which case the advance notice must be sent at least one month before. The announcement must state whether the Assembly is Ordinary or Extraordinary, and will state the date the meeting will be held on first call and all the matters to be addressed. Likewise, it shall also state the date on which, if appropriate, the Assembly will meet on second call, and there must be, at least, twenty-four hours between the first and second call. The announcement of the Assemblies, both Ordinary and Extraordinary, will also be sent individually to each shareholder by registered letter if they live in Spain, and airmail letter if they live abroad, at least fifteen days before the date scheduled for the Assembly. Article 15.- The General Shareholder Assembly, both Ordinary and Extraordinary, will be validly established on first call when the shareholders, present or represented, hold at least 25% of the subscribed capital with voting rights. On second call, the Assembly will be validly established regardless of the capital that is in attendance.

However, in order for the Ordinary or Extraordinary General Assembly to be able to validly agree to issue bonds, increase or reduce capital, transform, merge or split the Company and, in general, make any amendment to the Corporate Bylaws, it will require, on first call, the attendance of shareholders, present or represented, holding, at least, 50% of the subscribed capital with voting rights. On second call, the attendance of 25% of said capital will be enough. Notwithstanding the provisions in the paragraphs above, the Assembly shall be deemed to be convened and will be validly established to discuss any matter, whenever all the share capital is present and the attendees unanimously agree to hold the General Assembly. Article 16.- In order to attend the General Assemblies, it is essential for the shares to be registered in the Shares Registry Book, at least five days before the day on which the Assembly should be held. Any shareholder who is entitled to attend in accordance with the preceding paragraph may be represented at the Assembly by another person, even if they are not a shareholder, by means of a written authorization signed by the absent shareholder, specifying for which Assembly it is granted. Article 17.- Each share gives the right to one vote, and the Assembly’s agreements will be decided by the majority vote of those present or represented, except for those cases where the Law establishes a higher favorable vote. Article 18.- The General Assemblies will be held at the corporate address on the date and at the time indicated in the announcement. The Assemblies will be chaired by the assistant appointed for that purpose by the shareholders. The Chairman will be assisted by a Secretary, filling the role of assistant to the Assembly appointed for that purpose by the shareholders. The Chairman shall direct the discussions and may resolve the procedural issues that arise. Before starting on the items in the agenda, a list of attendees will be prepared, stating the nature or representation of each attendee and the number of shares, theirs and belonging to others, with which they attend the Assembly. The deliberations and decisions of the Assemblies will be recorded in the appropriate minutes in the corresponding book, with each Assembly’s minutes being approved in the legally established manner. The certificates of said minutes shall be issued by the persons authorized by the Law. Article 19.- The validly adopted agreements reached by the General Assemblies will be effective as of their approval in accordance with the provisions of Article 113 of the Corporations Act and will be binding on all shareholders, including those absent or dissenting, without the need for the approval of the minutes in a subsequent Assembly, and subject to the rights to challenge and separation, if any, that the Law grants to shareholders. SECOND CHAPTER: ON THE COMPANY MANAGEMENT. Article 20.- The Management and legal representation of the Company will fall on three Joint and Several Managers. The Managers will be freely appointed and dismissed by the General Assembly and shall serve for a term of five years, and they may be reelected one or more times for periods of equal maximum length. The General Shareholders Assembly shall determine the amount of the remuneration, which will consist of a share in the Company’s profits which shall not exceed 10% thereof, respecting the provisions of Article 130 of the Corporations Act. Article 21.- The Governing Body shall represent the Company, in and out of court, in whatever matters affect the Company’s business and affairs. TITLE V. ON THE ANNUAL ACCOUNTS AND APPLICATION OF RESULTS. Article 22.- The Governing Body must prepare, within a maximum period of three months from the close of the fiscal year, the annual accounts, that is, the Balance Sheet, the Profit and Loss Statement and the Notes, as well as the management report and the proposed application of results, for said fiscal year, with the requirements established by Law. The annual accounts and the management report must be reviewed by the Auditors, except when the Company may submit an abridged balance, as provided in the Corporations Act, and will be submitted to consideration by the shareholders, and to the consideration and approval, in its case, of the General Shareholders Assembly, with the requirements established in the Corporations Act. TITLE VI. TRANSFORMATION, MERGER, SPLIT, DISSOLUTION AND LIQUIDATION OF THE COMPANY. Article 23.- The Extraordinary General Shareholders Assembly, convened for that purpose, may arrange and carry out

the transformation, merger and split of the Company, complying at all times with the provisions in that regard of the Corporations Act and these Bylaws. Article 24.- The Company may be dissolved with the prior agreement of the General Shareholders Assembly and for any of the grounds specified in Article 260 of the Corporations Act. Article 25.- Once the dissolution has been agreed upon, the liquidation will take place, in its case, pursuant to the provisions of the Corporations Act. To that end, the General Shareholders Assembly shall appoint one or more liquidators, in an odd number, and will confer the appropriate mandate upon them. Article 26.- After the liquidation, the liquidator or liquidators will prepare the Final Balance Sheet and will determine the value of the corporate assets and the liquidation quota which corresponds to each share. GENERAL PROVISIONS. Article 27.- 1. Any question concerning the interpretation and application of these Corporate Bylaws that so requires, except those regulated by the Corporations Act, shall be settled by arbitration in equity, pursuant to Law 36/1988, of December 5. 2. Those persons declared incompatible under any precept may not hold positions in the Company, or exercise them.